Expertise in
5
conditions

Falk Hiepe

Berlin, BE, DE 
Expertise in
5
conditions
Berlin, BE, DE 

Overview

Falk Hiepe practices practicing medicine in Berlin, Germany.

Hiepe is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Glomerulonephritis, Vasculitis, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 112 peer reviewed articles and participating in 3 clinical trials.

Locations

Berlin, BE, Germany
Other Locations
Mitte, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

112 Total Publications

Potential new targets for rheumatic diseases.
Potential new targets for rheumatic diseases.
Journal: EULAR rheumatology open
Published: August 01, 2026

Frequently Asked Questions about Falk Hiepe

Is Falk Hiepe a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Falk Hiepe is classified as an Elite expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Falk Hiepe participate in research or clinical trials?

Yes. Falk Hiepe has published 112 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Falk Hiepe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hiepe's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile